The Chris Wolfe Podcast: The Real Reason Your IPL Device Isn’t Paying Off

Process Before Outcome: Why IPL and Photobiomodulation Need a Better Clinical Pathway

Christopher Wolfe, OD, FAAO, explores a common implementation mistake in eye care: pursuing an outcome before building the process that can produce it consistently. Using IPL and photobiomodulation as examples, he explains why the goal should be better identification, evaluation, and management of ocular surface disease and macular degeneration—not simply performing more procedures. He also discusses how clinical evidence, professional judgment, and patient preferences work together to support appropriate, sustainable care.

Key topics

Why practices may struggle to implement IPL even when they believe in the technology

The hidden workflows behind successful clinical programs

Why “more IPL treatments” is an incomplete measure of success

How a structured dry eye pathway can move patients from identification to evaluation and appropriate treatment

Why not every patient is a candidate for IPL—or wants a procedure

How research, clinical judgment, and patient preferences inform evidence-based care

How procedure-first goals can unintentionally influence conversations with patients

What a broader macular degeneration management pathway can include

Why photobiomodulation should be one possible treatment option, not the entire goal